This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1975 Oct;55(2):264P.

Proceedings: A correlation between the response to debrisoquine and the amount of unchanged drug excreted in the urine

M Angelo, L G Dring, R Lancaster, A Latham, R L Smith

PMID: 1201404
PMCID: PMC1666860

Proceedings: A correlation between the response to debrisoquine and the amount of unchanged drug excreted in the urine

M Angelo et al. Br J Pharmacol. 1975 Oct.

. 1975 Oct;55(2):264P.

Authors

M Angelo, L G Dring, R Lancaster, A Latham, R L Smith

PMID: 1201404
PMCID: PMC1666860

No abstract available

PubMed Disclaimer

Similar articles

Clinical trials with Tendor (debrisoquine sulfate).
Langer L, Gerö A. Langer L, et al. Ther Hung. 1974;22(4):165-71. Ther Hung. 1974. PMID: 4465961 No abstract available.
[On the hypotensive effect of debrisoquin sulfate (Declinax)].
Honorato F, Ortolá RP. Honorato F, et al. Rev Med Univ Navarra. 1973 Dec;17(4):339-44. Rev Med Univ Navarra. 1973. PMID: 4807215 Spanish. No abstract available.
A longitudinal study of the mechanisms of action of debrisoquine and propranolol.
Aminu J, Vere DW. Aminu J, et al. Br J Clin Pharmacol. 1978 Jul;6(1):43-50. doi: 10.1111/j.1365-2125.1978.tb01680.x. Br J Clin Pharmacol. 1978. PMID: 352376 Free PMC article. Clinical Trial.
Why hypertensive patients vary in their response to oral debrisoquine.
Silas JH, Lennard MS, Tucker GT, Smith AJ, Malcolm SL, Marten TR. Silas JH, et al. Br Med J. 1977 Feb 12;1(6058):422-5. doi: 10.1136/bmj.1.6058.422. Br Med J. 1977. PMID: 837136 Free PMC article.
Hypotensive response to debrisoquine and hydroxylation phenotype.
Idle JR, Mahgoub A, Lancaster R, Smith RL. Idle JR, et al. Life Sci. 1978 Mar;22(11):979-83. doi: 10.1016/0024-3205(78)90363-6. Life Sci. 1978. PMID: 642709 No abstract available.

See all similar articles

Cited by

3,4-Dehydrodebrisoquine, a novel debrisoquine metabolite formed from 4-hydroxydebrisoquine that affects the CYP2D6 metabolic ratio.
Zhen Y, Slanar O, Krausz KW, Chen C, Slavík J, McPhail KL, Zabriskie TM, Perlík F, Gonzalez FJ, Idle JR. Zhen Y, et al. Drug Metab Dispos. 2006 Sep;34(9):1563-74. doi: 10.1124/dmd.105.008920. Epub 2006 Jun 16. Drug Metab Dispos. 2006. PMID: 16782768 Free PMC article. Clinical Trial.
Personalized medicine - where do we stand? Pouring some water into wine: a realistic perspective.
Gundert-Remy U, Dimovski A, Gajović S. Gundert-Remy U, et al. Croat Med J. 2012 Aug;53(4):314-20. doi: 10.3325/cmj.2012.53.314. Croat Med J. 2012. PMID: 22911523 Free PMC article.
Importance of Publishing Adverse Drug Reaction Case Reports: Promoting Public Health and Advancing Pharmacology and Therapeutics.
Shah RR. Shah RR. Drug Saf Case Rep. 2017 Sep 20;4(1):11. doi: 10.1007/s40800-017-0053-0. Drug Saf Case Rep. 2017. PMID: 28933008 Free PMC article.
Polymorphic drug oxidation: pharmacokinetic basis and comparison of experimental indices.
Jackson PR, Tucker GT, Lennard MS, Woods HF. Jackson PR, et al. Br J Clin Pharmacol. 1986 Nov;22(5):541-50. doi: 10.1111/j.1365-2125.1986.tb02933.x. Br J Clin Pharmacol. 1986. PMID: 3790400 Free PMC article.
The metabolism of [14C]-debrisoquine in man.
Idle JR, Mahgoub A, Angelo MM, Dring LG, Lancaster R, Smith RL. Idle JR, et al. Br J Clin Pharmacol. 1979 Mar;7(3):257-66. doi: 10.1111/j.1365-2125.1979.tb00930.x. Br J Clin Pharmacol. 1979. PMID: 371651 Free PMC article.

References

1. Anal Chem. 1974 Jan;46(1):34-9 - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources